Indicators of hepatic fibrosis, such as Col1αI and α-SMA, were significantly reduced in mice treated with FT@XBP1 compared with FFC diet-fed mice at both mRNA (Fig. 6D) and protein levels (Fig. 6E). Here, ACTA1 is linked to Hepatic fibrosis.